Impact of Genetic Variants in Inosine Triphosphate Pyrophosphatase and Interferon-λ4 on Natural History, Treatment Response and Ribavirin Pharmacology in Hepatitis C Virus Infection

The HEV3 strains identified in drinking water were different from those isolated from Swedish pigs and wild boars, and similar to strains from humans with unknown source of

Hao Wang, Inger Kjellberg, Per Sikora, Henrik Rydberg, Magnus Lindh, Olof Bergstedt, Heléne Norder, Hepatitis E virus genotype 3 strains and a plethora of other viruses detected in

To clarify whether baseline intrahepatic IP-10 mRNA expression reflects baseline plasma IP-10 levels in predicting first phase viral decline and sustained

IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV.. Lagging M,

In the NORDynamIC study with 354 peg-IFNα2a and RBV treated chronic HCV genotype 2 or 3 infected patients, we were able to demonstrate that SNPs in ITPA reducing the activity

Impact of Genetic Variants in Inosine Triphosphate Pyrophosphatase and Interferon-λ4 on Natural History, Treatment Response and Ribavirin Pharmacology in Hepatitis C

genetic variants of PNPLA3, IL28B and ITPA, on liver disease severity and treatment outcome in HCV genotype 2 and 3 infected patients treated with pegylated interferon and

[r]